Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Sun Pharma launches RIOMET ER diabetes drug in the US

      Sun Pharma launches RIOMET ER diabetes drug in the US

      Medical Dialogues Bureau27 Feb 2020 4:30 PM IST
      Riomet ER™, dosed once daily, is the first and only FDA-approved liquid formulation of extended-release metformin.
      Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

      Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

      Medical Dialogues Bureau27 Feb 2020 3:00 PM IST
      State Governments and UTs are requested to closely monitor the production and availability of APIs and their formulations to prevent black marketing...
      Sourav Ganguly becomes the brand Ambassador for Piramals antacid Polycrol

      Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol

      Medical Dialogues Bureau27 Feb 2020 2:02 PM IST
      Available in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West...
      USFDA inspection at Cipla manufacturing facility in Goa, warning letter issued

      USFDA inspection at Cipla manufacturing facility in Goa, warning letter issued

      Medical Dialogues Bureau27 Feb 2020 1:56 PM IST
      New Delhi: Drug firm Cipla recently announced that it has received a warning letter from USFDA for its goa Manufacturing Facility.Pursuant to...
      APEIRON to start a pilot clinical trial  to treat coronavirus disease COVID-19 in China with APN01

      APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01

      Medical Dialogues Bureau27 Feb 2020 10:00 AM IST
      Vienna: APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, has...
      COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies

      COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies

      Medical Dialogues Bureau27 Feb 2020 9:00 AM IST
      WuXi Biologics will conduct cell-line development, process and formulation development, if the antibodies receive regulatory approvals, WuXi Biologics...
      USFDA identifies 20 drugs with shortage risks due to coronavirus outbreak

      USFDA identifies 20 drugs with shortage risks due to coronavirus outbreak

      Medical Dialogues Bureau26 Feb 2020 3:54 PM IST
      NEW YORK - The U.S. Food and Drug Administration has contacted producers of about 20 drugs that either source all of their main ingredients from or...
      Sanofi plans to create standalone company dedicated to making APIs

      Sanofi plans to create standalone company dedicated to making APIs

      Medical Dialogues Bureau26 Feb 2020 3:37 PM IST
      PARIS : Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically...
      Lupin launches Ethacrynic Acid Tablets USP, 25 mg

      Lupin launches Ethacrynic Acid Tablets USP, 25 mg

      Medical Dialogues Bureau26 Feb 2020 3:27 PM IST
      The product would be manufactured at Lupin's Nagpur OSD facility, India.
      Gileads drug leads global race to find virus treatment

      Gilead's drug leads global race to find virus treatment

      Medical Dialogues Bureau26 Feb 2020 2:24 PM IST
      Beijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
      Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh

      Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh

      Medical Dialogues Bureau25 Feb 2020 4:28 PM IST
      Beximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
      FDA authorizes marketing of the first genetic test for Fragile X Syndrome

      FDA authorizes marketing of the first genetic test for Fragile X Syndrome

      Medical Dialogues Bureau25 Feb 2020 2:09 PM IST
      US: The U.S. Food and Drug Administration has authorized marketing of the test to detect a genetic condition known as Fragile X Syndrome (FXS), the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok